Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Male fertility diagnostics leaders, Examen, now offer semen analysis testing for men in Belfast

    Mar 11, 2022, 14:08 PM by
    Examen, leaders in male fertility research and diagnostics, is delighted to announce that semen analysis is now available at its Belfast facility. This comes in response to unprecedented demand for fertility services as couples continue to face delays in accessing appointments owing to the backlog caused by the pandemic.
    Full story
  • Cotiviti to Present on Strategies to Align Payer and Provider Risk Adjustment Programs within Value-Based Care at 2022 RISE National Summit

    Mar 11, 2022, 14:08 PM by
    Summit to be co-chaired by Cotiviti Executive Vice President RaeAnn Grossman
    Full story
  • UK Regulator Cites CluePoints’ Solutions in Updated Guidance

    Mar 11, 2022, 14:08 PM by
    UK Regulator Cites CluePoints’ Solutions in Updated Guidance MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions.
    Full story
  • Alfa Chemistry Announces Completion of Building a Sub-website for Polymer Stabilizers

    Mar 11, 2022, 14:08 PM by
    Full story
  • CD Formulation Announces Ability to Achieve Solubility Improvement and Bioavailability Enhancement for Drug Formulation Projects

    Mar 11, 2022, 14:08 PM by
    Full story
  • Oxford Medical Products raises £2.5 million for its hydrogel weight-loss platform technology

    Mar 11, 2022, 14:08 PM by
    Oxford Medical Products has raised £2.5M in equity investment to conduct first human trials of Sirona, its innovative non-surgical weight-loss solution. Sirona is a hydrogel-based technology in a tablet format that, once swallowed, expands in the stomach, stops feelings of hunger and suppresses appetite.
    Full story
  • Aragen acquires Intox Pvt. Ltd

    Mar 11, 2022, 14:08 PM by
    Full story
  • Watson-Marlow Fluid Technology Group drives growth with new Operations and Supply Director

    Mar 11, 2022, 14:08 PM by
    Abdul Butt joins Watson-Marlow Fluid Technology Group as Operations and Supply Director to drive the company’s supply excellence and enable continued growth. Abdul joins the company with extensive experience in Manufacturing and Operational Excellence, including 20 years at GKN PLC and then Melrose Industries as CEO of one of their divisions, followed by MPP where he was Chief Operating Officer in his most recent role.
    Full story
  • NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer

    Mar 11, 2022, 14:08 PM by
    NanoSyrinx has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer.
    Full story
  • Senior Biopharma Executive Joins MMS Holdings as Principal Medical Director

    Mar 11, 2022, 14:08 PM by
    MMS Holdings, a data-focused contract research organization (CRO), announced the addition of Robert Allen, MD, to its team as Principal Medical Director of Global Drug Safety and Pharmacovigilance.
    Full story
  • Vyasa Introduces Cortex: Intuitive, Visual Data Fabric Creation & Management

    Mar 11, 2022, 14:08 PM by
    Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today debuts its latest application, Cortex. An intuitive data management tool, Cortex acts as the “blueprint” of the data fabric by allowing users to build, manage and provision access to data sources connected to Vyasa Layar data fabrics.
    Full story
  • Emmes Acquires Casimir, Its Fourth Major Acquisition

    Mar 11, 2022, 14:08 PM by
    Full story
  • Japan tops CPhI ‘API Quality’ ranking for second year

    Mar 11, 2022, 14:08 PM by
    Full story
  • New Tactic Proposed To Find Drugs For Alzheimer’s Disease

    Mar 10, 2022, 01:00 AM by User Not Found
    Bio-IT World | A new method to screen drugs for treating Alzheimer’s disease could significantly improve the odds of therapeutic success by analyzing causal mechanisms in human neurons, according to Shankar Subramaniam, professor of bioengineering at the University of California (UC) San Diego. The plan now is to extend the work to organoids with microglia cells and vasculature, creating “realistic human brain avatars” for better understanding disease endotypes and their response to treatment.
    Full story
  • How to Manage Data as an Asset: Opinions from a Fortune 5 Executive

    Mar 8, 2022, 01:00 AM by User Not Found
    Bio-IT World | As Executive Director of Enterprise Data Engineering and Analytics at CVS Health, Saira Kazmi uses her background in computer science and engineering in both academic and industry positions to inform her new role. She learned about the importance of iterative testing under the tightest timelines from the industry and got a first-hand view of the engineering rigor required to enable bioinformatics from her academic career. Now she is focused on creating data assets and managing the data life cycle at the enterprise level for a major healthcare player.
    Full story
  • Hormone-Producing Intestinal Cells Could Be Tapped As A Weight-Loss Remedy

    Mar 7, 2022, 01:00 AM by User Not Found
    Bio-IT World | An organoid model is being used to flush out what’s behind production of a rare subset of cells in the human intestine and the hormones they manufacture, including four that seem to have the most effect on decreasing appetite.
    Full story
  • Genentech Builds Single Cell Proteomics Platform for Real Time Mass Spec Analysis

    Mar 3, 2022, 01:00 AM by User Not Found
    Bio-IT World | Our technical capabilities are becoming increasingly granular, and proteomics is no exception. At the recent Molecular & Precision Med TRI-CON, Christopher Rose reported on how his group within the Microchemistry, Proteomics & Lipidomics department at Genentech where he currently leads the Discovery Proteomics group is working to build a single-cell proteomics platform.
    Full story
  • Cloud IT, Structural Variants, AI for Cancer, More

    Mar 2, 2022, 15:01 PM by User Not Found
    Bio-IT World | Structural variant detection in FFPE samples, new federated network for genomic variant surveillance, Element Biosciences’ new acquisitions and collaborations, RNA profiling to predict preterm birth, release of multi-modal mental health dataset, AI in genetic variant analysis for cancer and beta-propeller protein-associated neurodegeneration, and more.
    Full story
  • Follow the Money: ML in Immunology, Virtual Drug Screening; Single-Cell Multi-Omic Sequencing; AI Marketplace

    Feb 28, 2022, 11:48 AM by User Not Found
    Bio-IT World | AI and ML in immunological therapeutic development, virtual drug screening, microscope-based rapid pathogen diagnostics, improved genetic variant interpretation, and more.
    Full story
  • IDMP as a Tool for Better Organizational Data

    Feb 25, 2022, 01:00 AM by User Not Found
    Bio-IT World | The clock is ticking on implementing the EMA's IDMP standard. With the release of EU IG v2.1, the industry is in the final stages of preparations for optional submission. While regulatory teams have made progress applying guidance to uniquely identify products and standardize information, more work remains to establish a proper data foundation that supports submissions under the new requirements.
    Full story
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149 (current)
  • 150
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy